| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 631 | 142 | 131 | 203 | 164 | 318 | 250 | 318 | 343 | 191 |
| Gross Profit/Loss - EUR | -631 | -142 | -130 | -203 | -164 | -318 | -250 | -318 | -343 | -191 |
| Net Profit/Loss - EUR | -631 | -142 | -130 | -203 | -164 | -318 | -250 | -318 | -343 | -191 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Urorad Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 45.783 | 45.174 | 44.325 | 43.278 | 42.368 | 41.612 | 40.812 | 40.924 | 40.942 | 40.367 |
| Inventories | 42.076 | 41.647 | 40.943 | 40.191 | 39.413 | 38.666 | 37.808 | 37.926 | 37.811 | 37.599 |
| Receivables | 3.081 | 3.077 | 3.049 | 3.029 | 3.001 | 3.002 | 2.993 | 3.062 | 3.117 | 2.980 |
| Cash | 626 | 450 | 334 | 58 | -47 | -56 | 10 | -64 | 15 | -212 |
| Shareholders Funds | 43.694 | 43.106 | 42.246 | 41.268 | 40.305 | 39.223 | 38.103 | 37.903 | 37.445 | 37.045 |
| Social Capital | 450 | 445 | 438 | 430 | 421 | 413 | 404 | 406 | 404 | 402 |
| Debts | 2.089 | 2.068 | 2.079 | 2.010 | 2.062 | 2.389 | 2.708 | 3.021 | 3.497 | 3.322 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Urorad Med S.r.l.